These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27249098)

  • 1. In brief: new indications for secukinumab (Cosentyx).
    Med Lett Drugs Ther; 2016 Jun; 58(1496):76. PubMed ID: 27249098
    [No Abstract]   [Full Text] [Related]  

  • 2. Golimumab (simponi) for inflammatory arthritis.
    Med Lett Drugs Ther; 2009 Jul; 51(1316):55-6. PubMed ID: 19590489
    [No Abstract]   [Full Text] [Related]  

  • 3. Secukinumab for the treatment of psoriatic arthritis.
    Baronaite Hansen R; Kavanaugh A
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1027-36. PubMed ID: 27550397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ustekinumab for psoriasis and psoriatic arthritis.
    Goldminz AM; Gottlieb AB
    J Rheumatol Suppl; 2012 Jul; 89():86-9. PubMed ID: 22751602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secukinumab: first global approval.
    Sanford M; McKeage K
    Drugs; 2015 Feb; 75(3):329-38. PubMed ID: 25648267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Voulgari PV
    Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini M; Viapiana O; Orsolini G; Fracassi E; Idolazzi L; Gatti D; Adami S; Govoni M
    Reumatismo; 2015 Mar; 66(4):285-303. PubMed ID: 25829189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study].
    Bunchuk NV; Rumiantseva OA; Loginova EIu; Bochkova AG; Storozhakov GI; Ettinger OA; Kosiura SD; Kamalova RG; Valishina LM
    Ter Arkh; 2010; 82(10):41-6. PubMed ID: 21341463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secukinumab: A Review in Psoriatic Arthritis.
    Shirley M; Scott LJ
    Drugs; 2016 Jul; 76(11):1135-45. PubMed ID: 27299434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
    Alabed IB; Qushmaq KA; Khan MA
    Saudi Med J; 2010 Sep; 31(9):1054-6. PubMed ID: 20844821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secukinumab: A Review in Ankylosing Spondylitis.
    Blair HA
    Drugs; 2019 Mar; 79(4):433-443. PubMed ID: 30793255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab: A Review in Ankylosing Spondylitis.
    Blair HA; Dhillon S
    Drugs; 2016 Jul; 76(10):1023-30. PubMed ID: 27255593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases.
    Godhwani S; Gruber BL; Finzel K
    J Clin Rheumatol; 2015 Jan; 21(1):53-5. PubMed ID: 25539441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological treatment of psoriasis and psoriatic arthritis].
    Kragballe K; Deleuran B
    Ugeskr Laeger; 2008 Jun; 170(24):2148-50. PubMed ID: 18565300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golimumab.
    Mazumdar S; Greenwald D
    MAbs; 2009; 1(5):422-31. PubMed ID: 20065639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
    Chimenti MS; Fonti GL; Conigliaro P; Sunzini F; Scrivo R; Navarini L; Triggianese P; Peluso G; Scolieri P; Caccavale R; Picchianti Diamanti A; De Martino E; Salemi S; Birra D; Altobelli A; Paroli M; Bruzzese V; Laganà B; Gremese E; Conti F; Afeltra A; Perricone R
    Expert Opin Biol Ther; 2020 Jul; 20(7):813-821. PubMed ID: 32401062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.
    Lozeron P; Denier C; Lacroix C; Adams D
    Arch Neurol; 2009 Apr; 66(4):490-7. PubMed ID: 19364934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ankylosing spondylitis and other spondyloarthritides.
    Braun J; Baraliakos X
    Curr Opin Rheumatol; 2009 Jul; 21(4):324-34. PubMed ID: 19461519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of infliximab and granulocyte/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis.
    Fujisawa T; Moriya C; Shibuya Y; Kanoh H; Seishima M
    Acta Derm Venereol; 2013 May; 93(3):364-5. PubMed ID: 23007291
    [No Abstract]   [Full Text] [Related]  

  • 20. Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Oldfield V; Plosker GL
    BioDrugs; 2009; 23(2):125-35. PubMed ID: 19489653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.